{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:03:23Z","timestamp":1715979803136},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00059-014-4158-2","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T07:38:39Z","timestamp":1414395519000},"page":"819-821","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombozyt\u00e4re Therapie und PCI"],"prefix":"10.1007","volume":"39","author":[{"given":"B.","family":"Scheller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"4158_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","volume":"1","author":"Gruntzig","year":"1978","unstructured":"Gruntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263","journal-title":"Lancet"},{"key":"4158_CR2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V et al (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701\u2013706","journal-title":"N Engl J Med"},{"key":"4158_CR3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","volume":"339","author":"Leon","year":"1998","unstructured":"Leon MB, Baim DS, Popma JJ et al (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339:1665\u20131671","journal-title":"N Engl J Med"},{"key":"4158_CR4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"Sch\u00f6mig","year":"1996","unstructured":"Sch\u00f6mig A, Neumann FJ, Kastrati A et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084\u20131089","journal-title":"N Engl J Med"},{"key":"4158_CR5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315\u20131323","journal-title":"N Engl J Med"},{"key":"4158_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221\u2013231","journal-title":"N Engl J Med"},{"key":"4158_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193\u2013202","journal-title":"J Am Coll Cardiol"},{"key":"4158_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"Virmani","year":"2004","unstructured":"Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701\u2013705","journal-title":"Circulation"},{"key":"4158_CR9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/hc3101.092214","volume":"104","author":"Hwang","year":"2001","unstructured":"Hwang CW, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104:600\u2013605","journal-title":"Circulation"},{"key":"4158_CR10","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","volume":"48","author":"Pfisterer","year":"2006","unstructured":"Pfisterer M, Brunner-La Rocca HP, Buser PT et al (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48:2584\u20132591","journal-title":"J Am Coll Cardiol"},{"key":"4158_CR11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","volume":"115","author":"Camenzind","year":"2007","unstructured":"Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115:1440\u20131455","journal-title":"Circulation"},{"key":"4158_CR12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"Lagerqvist","year":"2007","unstructured":"Lagerqvist B, James SK, Stenestrand U et al (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009\u20131019","journal-title":"N Engl J Med"},{"key":"4158_CR13","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Authors","year":"2014","unstructured":"Authors\/Task Force members, Windecker S, Kolh P et al (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541\u20132619","journal-title":"Eur Heart J"},{"key":"4158_CR14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12181-011-0375-6","volume":"6","author":"Scheller","year":"2011","unstructured":"Scheller B, Levenson B, Joner M et al (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter: Positionspapier der DGK 2011. Kardiologe 6:411\u2013435","journal-title":"Kardiologe"},{"key":"4158_CR15","doi-asserted-by":"crossref","first-page":"K125","DOI":"10.4244\/EIJV7SKA21","volume":"7","author":"Kleber","year":"2011","unstructured":"Kleber FX, Mathey DG, Rittger H et al (2011) How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention 7:K125\u2013K128","journal-title":"EuroIntervention"},{"key":"4158_CR16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","volume":"102","author":"Kleber","year":"2013","unstructured":"Kleber FX, Rittger H, Bonaventura K et al (2013) Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 102:785\u2013797","journal-title":"Clin Res Cardiol"},{"key":"4158_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ccd.25149","volume":"83","author":"Cortese","year":"2014","unstructured":"Cortese B, Berti S, Biondi-Zoccai G et al (2014) Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv 83:427\u2013435","journal-title":"Catheter Cardiovasc Interv"},{"key":"4158_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic","year":"2002","unstructured":"Antithrombotic Trialists\u2018 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"key":"4158_CR19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","volume":"376","author":"Mehta","year":"2010","unstructured":"Mehta SR, Tanguay JF, Eikelboom JW et al (2010) Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 376:1233\u20131243","journal-title":"Lancet"},{"key":"4158_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","volume":"305","author":"Price","year":"2011","unstructured":"Price MJ, Berger PB, Teirstein PS et al (2011) Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097\u20131105","journal-title":"JAMA"},{"key":"4158_CR21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","volume":"60","author":"Wohrle","year":"2012","unstructured":"Wohrle J, Zadura M, Mobius-Winkler S et al (2012) SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 60:1733\u20131738","journal-title":"J Am Coll Cardiol"},{"key":"4158_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/heartjnl-2013-304881","volume":"100","author":"Zeymer","year":"2014","unstructured":"Zeymer U, Waliszewski M, Spiecker M et al (2014) Prospective \u201areal world\u2018 registry for the use of the \u201aPCB only\u2018 strategy in small vessel de novo lesions. Heart 100:311\u2013316","journal-title":"Heart"},{"key":"4158_CR23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","volume":"382","author":"Mehran","year":"2013","unstructured":"Mehran R, Baber U, Steg PG et al (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382:1714\u20131722","journal-title":"Lancet"},{"key":"4158_CR24","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","volume":"348","author":"Windecker","year":"2014","unstructured":"Windecker S, Stortecky S, Stefanini GG et al (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859","journal-title":"BMJ"},{"key":"4158_CR25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","volume":"369","author":"Erbel","year":"2007","unstructured":"Erbel R, Di Mario C, Bartunek J et al (2007) Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369:1869\u20131875","journal-title":"Lancet"},{"key":"4158_CR26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","volume":"373","author":"Serruys","year":"2009","unstructured":"Serruys PW, Ormiston JA, Onuma Y et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897\u2013910","journal-title":"Lancet"},{"key":"4158_CR27","doi-asserted-by":"crossref","unstructured":"Serruys PW, Chevalier B, Dudek D et al (2014) A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet [Epub ahead of print]","DOI":"10.1016\/S0140-6736(14)61455-0"},{"key":"4158_CR28","doi-asserted-by":"crossref","unstructured":"Capodanno D, Gori T, Nef H et al (2014) Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention [Epub ahead of print]","DOI":"10.4244\/EIJY14M07_11"},{"key":"4158_CR29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/hrt.2011.226563","volume":"97","author":"Wohrle","year":"2011","unstructured":"Wohrle J, Birkemeyer R, Markovic S et al (2011) Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 97:1338\u20131342","journal-title":"Heart"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4158-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4158-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T17:24:08Z","timestamp":1565976248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4158-2"}},"subtitle":["Therapiedauer nach DCB\/Stents\/Scaffolds"],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4158-2","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}